Few studies have characterised IL-13 expression in gliomas with the majority of research focused on the IL-13 receptor subunit alpha-2 (IL-13Rα2), which was shown to be aberrantly expressed in almost 80% of glioblastoma samples [25]. This evidence concerns the gene IL13 and central nervous system cancer.